AI English summary of an SEC filing — figures as filed
The company said CMS approved the Medicaid managed care component of the Nevada State Directed Payment Program (SDP) in late December 2023, with an effective date of January 1, 2024.
Key points
AI summaryThe company said CMS approved the Medicaid managed care component of the Nevada State Directed Payment Program (SDP) in late December 2023, with an effective date of January 1, 2024.
Based on financial data provided by DHCFP for its Nevada facilities, the company estimates that net reimbursements from this component, net of related provider taxes, will approximate $140 million for the year ending December 31, 2024.
The company estimated net reimbursements of $18 million from the Medicaid fee for service upper payment limit component, approved by CMS in November 2023 and December. It said the two components combined, net of provider taxes, will approximate $158 million for 2024.
The company said payments under this component require annual CMS approval and are subject to DHCFP reconciliation based on actual Medicaid managed care utilization in 2024. It added that there can be no assurance the component will continue after December 31, 2024 or that it will not be modified.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
CMS Approves Nevada SDP Medicaid Managed Care Component
The company said CMS approved the Medicaid managed care component of the Nevada State Directed Payment Program (SDP) in late December 2023, with an effective date of January 1, 2024.
Source · Based on the filing body and exhibits
Estimates Net Reimbursements of About $140 million for Medicaid Managed Care Component
Based on financial data provided by DHCFP for its Nevada facilities, the company estimates that net reimbursements from this component, net of related provider taxes, will approximate $140 million for the year ending December 31, 2024.
Source · Based on the filing body and exhibits
Fee for Service Upper Payment Limit Component $18 million and Combined $158 million
The company estimated net reimbursements of $18 million from the Medicaid fee for service upper payment limit component, approved by CMS in November 2023 and December. It said the two components combined, net of provider taxes, will approximate $158 million for 2024.
Source · Based on the filing body and exhibits
Annual CMS Approval Required, Subject to DHCFP Reconciliation and Continuation Uncertain
The company said payments under this component require annual CMS approval and are subject to DHCFP reconciliation based on actual Medicaid managed care utilization in 2024. It added that there can be no assurance the component will continue after December 31, 2024 or that it will not be modified.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…